| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.0B | $15.7B | $20.4B | $33.4B | $15.9B | $2.8B | $3.0B | $2.4B |
| Cost of Revenue | — | — | — | — | — | — | — | $4.6B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.4B | $0.4B | $0.5B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B |
| Operating Income | $9.1B | $6.1B | $15.5B | $4.6B | $-0.7B | $0.3B | $1.0B | $0.5B |
| Net Income | $5.3B | $3.3B | $9.9B | $1.4B | $-2.3B | $-0.2B | $0.9B | $0.1B |
| EPS (Basic) | $24.19 | $14.24 | $40.99 | $5.69 | $-9.25 | $-0.77 | $3.70 | $0.26 |
| EPS (Diluted) | $24.13 | $14.20 | $40.72 | $5.64 | $-9.25 | $-0.77 | $3.34 | $0.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $47.9B | $43.9B | $43.1B | $41.3B | $39.3B | $35.7B | $35.5B | $32.0B |
| Current Assets | $3.7B | $4.8B | $6.3B | $5.6B | $5.1B | $3.2B | $4.2B | $4.2B |
| Cash & Equivalents | $1.1B | $2.6B | $4.1B | $1.4B | $1.4B | $1.6B | $2.5B | $1.0B |
| Total Liabilities | $34.8B | $33.8B | — | — | — | — | — | — |
| Current Liabilities | $3.9B | $4.4B | $3.9B | $6.8B | $4.7B | $2.2B | $1.9B | $1.7B |
| Stockholders' Equity | $7.9B | $5.7B | $5.1B | $-3.0B | $-2.6B | $-0.2B | $-0.0B | $-0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.5B | $5.4B | $8.4B | $10.5B | $2.5B | $1.3B | $1.8B | $2.0B |
| Investing Cash Flow | $-3.0B | $-2.3B | $-2.2B | $-1.8B | $-0.9B | $-1.9B | $-3.2B | $-3.7B |
| Capital Expenditures | $3.1B | $2.2B | $2.1B | $1.8B | $1.0B | $1.8B | $3.1B | $3.6B |
| Financing Cash Flow | $-4.1B | $-4.5B | $-4.2B | $-8.0B | $-1.8B | $-0.2B | $1.2B | $2.2B |